Skip to main content
. 2024 Feb 14;10:35. doi: 10.1038/s41531-024-00646-w

Table 6.

Regression model outputs in PD: CSF biomarkers (pg/mL).

Model a-Synuclein (a-syn) Amyloid-b CSF p-tau (2016 assay)
PD PD-F PD-M PD-M* PD PD-F PD-M PD-M* PD PD-F PD-M PD-M*
R2 0.092 0.234 0.033 0.034 0.045 0.089 0.028 0.020 0.08 0.11 0.07 0.06
F (p-value) 6.091 (<0.001) 9.350 (<0.001) 1.540 (0.219) 1.062 (0.399) 2.746 (0.018) 2.882 (0.034) 1.645 (0.191) 0.612 (0.663) 4.824 (<0.001) 3.603 (0.013) 4.085 (0.005) 1.668 (0.191)
Brain-PAD b −15.45 −32.68 −8.89 −10.69 −10.39 −19.479 −6.897 −7.799 −0.050 −0.160 −0.015 0.049
t −3.117 −3.644 −1.517 −1.251 −3.280 −2.890 −2.010 −1.505 −1.206 −1.753 −0.328 0.707
p 0.002 <0.001 0.131 0.213 0.001 0.005 0.046 0.135 0.229 0.082 0.743 0.481
Actual age b 10.51 15.43 8.042 5.669 0.577 0.849 0.651 −0.097 0.135 0.168 0.122 0.101
t 2.988 2.624 1.866 0.977 0.256 0.190 0.259 −0.028 4.684 2.893 3.837 2.126
p 0.003 0.010 0.063 0.331 0.798 0.850 0.796 0.978 <0.001 0.005 <0.001 0.035
Duration b 12.13 27.21 0.624 11.672 0.944 9.153 −4.865 −1.162 0.024 0.106 −0.047 0.058
t 2.330 3.580 0.090 1.238 0.283 1.583 −1.204 −0.203 0.565 1.501 −0.903 0.523
p 0.020 <0.001 0.928 0.218 0.777 0.116 0.230 0.839 0.573 0.136 0.368 0.601
Education b −3.129 4.472 −6.392 −13.122 −4.139 5.271 −9.018 −5.135 0.067 0.050 0.080 0.110
t −0.262 0.227 −0.433 −0.697 −0.544 0.355 −1.051 −0.452 0.696 0.269 0.736 0.676
p 0.794 0.821 0.666 0.487 0.587 0.723 0.294 0.652 0.487 0.789 0.462 0.500
Sex b 106.4 26.29 0.543
t 1.466 0.564 0.922
p 0.144 0.573 0.357

PD Parkinson’s disease, F females, M males, M* matched males. Significant results are highlighted in bold. The p-values of the F-statistics were adjusted for multiple comparisons using the FDR technique.